Polaryx Therapeutics, Inc. PLYX
1.77 USD -0.14 (-7.09%)
At closeNov 13, 2026, 4:00 PM EST
1.83 +0.06 +3.39%
After hours · Nov 13, 4:00 PM ET
1.77 Day range 1.88
1.73 52-week range 35.00
- YTD
- -94.94%
- 1 year
- -94.94%
- Market cap
- 83.80M
- EPS (ttm)
- -0.14
- YTD return
- -94.94%
- 1-year return
- -94.94%
- Volume
- 10.40K
- Avg volume
- 46.60K
- Open
- 1.88
- Previous close
- 1.91
- Day's range
- 1.77 – 1.88
- 52-week range
- 1.73 – 35.00
5D +0.20 (+11.43%)
Financials — quick view
PLYX Revenue — quarterly 0
PLYX Net income — quarterly -1.38M
PLYX EPS — quarterly -0.03
News
Polaryx Therapeutics Q3 EPS $(0.07) Misses $(0.04) Estimate 
Polaryx Therapeutics Announces Activation Of First Clinical Trial Site For SOTERIA For Eligible Pediatric Participants 
Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200 
Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket 
This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday 
Raymond James Initiates Coverage On Polaryx Therapeutics with Strong Buy Rating, Announces Price Target of $6 
12 Health Care Stocks Moving In Friday's Pre-Market Session - LUCID CAPITAL MARKETS Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $7
- HC Wainwright & Co. Initiates Coverage On Polaryx Therapeutics with Buy Rating, Announces Price Target of $7
12 Health Care Stocks Moving In Tuesday's After-Market Session
Your note
Sign in to keep a note on PLYX — it syncs with the Stock Master app.